Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer

Susan Tsai1, Douglas B Evans1

  • 1LaBahn Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Insights

Investigator-initiated trials (IITs) empower clinicians to lead research, optimizing therapies when industry or cooperative groups lack support. Surgeons play a key role in developing these vital clinical trials.

Area of Science:

  • Clinical Research
  • Surgical Innovation
  • Medical Trials

Background:

  • Investigator-initiated trials (IITs) are crucial for advancing medical treatments.
  • IITs facilitate research not typically supported by industry or cooperative groups.
  • Clinicians serve as both sponsors and investigators in IITs.

Discussion:

  • The investigator's role in IITs is comprehensive, encompassing protocol design, funding acquisition, subject recruitment, and ethical oversight.
  • Surgeons are vital in developing IITs, contributing clinical expertise and driving research relevant to surgical practice.
  • Understanding and overcoming logistical challenges are crucial for successful IIT execution.

Key Insights:

  • IITs provide a critical platform for advancing medical knowledge and treatment paradigms.
  • The comprehensive responsibilities of an investigator require strong organizational and leadership skills.
  • Surgeons' involvement in IITs can lead to significant advancements in patient care and surgical techniques.

Outlook:

  • Future IITs will likely focus on personalized medicine and innovative treatment modalities.
  • Addressing logistical barriers through collaborative efforts and streamlined processes will enhance IIT success rates.
  • Continued surgeon engagement in IITs is essential for translating research into clinical practice.